Today's IPO for Mangoceuticals, Inc. (MGRX) opened for trading at $4.20 after pricing 1,250,000 shares of its common stock a $4.
Boustead Securities, LLC is acting as the sole managing underwriter for the offering.
Mangoceuticals, Inc. is a company focused on developing, marketing and selling a variety of men's health and wellness products and services via a secure telemedicine platform. To date, the Company has identified men's wellness telemedicine services and products as a growing sector and especially related to the area of erectile dysfunction (ED).